Hôpital Cardiologique Haut Lévêque
Pessac, France, 33604
Location status: Recruiting
NCT Number: NCT07255144
About 13 in 1000 children are born with heart disease. Current tools poorly assess heart filling in children, limiting treatment. This study explores ultrafast ultrasound imaging to measure heart stiffness and perfusion in children with congenital heart disease.
Interested in participating?
Request InfoAll sexes
Observational
Pessac, France, 33604
Location status: Recruiting
About 13/1000 children are born with heart disease. As a result of better treatment, there is an increasing population of children surviving with congenital heart disease (CHD) as well as a growing number of children with obesity, hypertension and serious chronic diseases, such as cancer and kidney disease, who are at risk of developing heart disease. All of these diseases affect the heart muscle and one of the main mechanisms resulting in heart muscle damage is the development of scar tissue (fibrosis). Fibrosis makes the heart muscle stiffer and therefore more difficult to fill. The heart must fill properly with blood in order to function well; but it is very difficult to study the filling of the heart using current diagnostic tools. One of the main challenges in pediatric cardiology is that non-invasive diagnostic approaches used in adult patients to assess heart filling (diastolic function) have proven inadequate in children. This knowledge gap has limited therapeutic progress in this vulnerable population; and to date there is no effective therapy that improves the filling of the heart.
The aim of this study is to explore new potential of ultrasound to assess diastolic function in CHD children. Ultrafast ultrasound imaging (UFUS), consisting of ultrasound images at a very high rate, is a new ultrasound approach to assess cardiac function.
Using a Verasonics system (ultrasound open platform), we will assess the myocardial stiffness and the myocardial perfusion by UFUS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrafast ultrasound imaging(UFUS), ultrasound images at a very high rate, using a Verasonics system (ultrasound open platform).
Time frame: Baseline
assessed with ultrasound data processed using the Verasonics system, to evaluate diastolic function
Time frame: Baseline
assessed with ultrasound data processed using the Verasonics system, to evaluate diastolic function
Time frame: Baseline
Contact information is provided by the study sponsor or research team.
University Hospital, Bordeaux
Other
Ultrafast Ultrasound Imaging: Application in Pediatric Cardiology: Cardiac Ultrafast
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686341
CHD - Congenital Heart Disease, Cardiovascular Abnormalities
Memphis, Tennessee, United States
View Trial DetailsNCT04216927
AKI, CHD - Congenital Heart Disease
Cincinnati, Ohio, United States
View Trial DetailsNCT07299721
CHD - Congenital Heart Disease, Cardiovascular Abnormalities
Pessac, France
View Trial DetailsNCT07115589
CHD - Congenital Heart Disease, Cardiovascular Abnormalities
Pessac, France
View Trial Details